TVRD
Tvardi Therapeutics, Inc.
1.10$
-19.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 33.2% | 23.0% | 29.0% | 0.5% | 2.9% | – | 0.0% | – | – | – | – | – | – | |
| 66.8% | 77.0% | 71.0% | -0.5% | 97.1% | 97.1% | 100.0% | – | – | – | – | – | – | |
| 522.5% | 944.5% | 1,028.8% | 659.0% | 187.6% | 591.3% | 12.4% | – | – | – | – | – | – | |
| – | 22.7% | 317.8% | 65.6% | 32.8% | 147.7% | 180.5% | – | – | – | – | – | – | |
| 660.6% | 1,162.5% | 1,460.5% | 724.1% | 222.1% | 742.4% | 192.9% | – | – | – | – | – | – | |
| -593.9% | -1,085.5% | -1,389.5% | -724.6% | -222.1% | -742.4% | -92.9% | – | – | – | – | – | – | |
| – | – | 92.8% | 192.7% | 76.7% | 180.1% | 111.6% | – | – | – | – | – | – | |
| -576.1% | -1,076.5% | -1,437.8% | -703.8% | -215.7% | -873.3% | -191.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -27.4% | – | – | – | – | – | – | – | |
| -576.1% | -1,076.5% | -1,437.8% | -703.8% | -215.7% | -873.3% | -191.0% | – | – | – | – | – | – | |
| -565.4% | -1,053.6% | -1,343.0% | -703.3% | -138.1% | -691.5% | -78.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.